Literature DB >> 32044636

EDTA, oxalate, and phosphate ions enhanced reactive oxygen species generation and sulfamethazine removal by zero-valent iron.

Yuwei Pan1, Minghua Zhou2, Qi Wang3, Jingju Cai3, Yusi Tian3, Ying Zhang4.   

Abstract

The activation rate of oxygen by zero-valent iron (Fe°) was very low. In this study, ethylenediaminetetraacetic acid (EDTA), oxalate (Ox), and phosphate ions (Na2HPO4) were used to enhance the oxygen activation by Fe° for sulfamethazine (SMT) removal. The addition of these ligands could significantly enhance the SMT degradation. SMT removal was improved from 10.5 % in the Fe° system (360 min) to 70.3 %, 85.2 % and 77.8 % in the Fe°/EDTA (60 min), Fe°/Ox (180 min) and Fe°/phosphate (360 min) systems, respectively. Scanning electron microscopy with energy dispersive X-ray (SEM-EDX), Fourier transform infrared reflection (FTIR), contact angle and X-ray photoelectron spectra (XPS) of Fe° in different systems were recorded. The presence of chelating agents hydroxylated Fe°, inhibited the iron oxide formation on the Fe° surface and promoted iron ion release from the solid. Moreover, the agents improved the recovery of surface Fe2+ which could subsequently enhance the activation of O2 to produce more H2O2 and reactive oxygen radicals for SMT removal. OH radical produced mainly through H2O2 decomposition was primarily responsible for removing SMT in all three systems. The Fe° system added with chelating agents is a new and promising approach for treating wastewaters containing ligands.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ethylenediaminetetraacetic acid; Fe(0); Oxalate; Oxygen activation; Phosphate ions

Year:  2020        PMID: 32044636     DOI: 10.1016/j.jhazmat.2020.122210

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

1.  Bi/mZVI Combined with Citric Acid and Sodium Citrate to Mineralize Multiple Sulfa Antibiotics: Performance and Mechanism.

Authors:  Xiaoming Su; Hao Lv; Jianyu Gong; Man Zhou
Journal:  Antibiotics (Basel)       Date:  2022-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.